Ligand-mediated conformational changes and positioning of tryptophans in reconstituted human sodium/D-glucose cotransporter1 (hSGLT1) probed by tryptophan fluorescence.
Recombinant purified human sodium/D-glucose cotransporter1 (hSGLT1) was reconstituted in a functional form into phospholipid vesicles and its conformational states in the absence and presence of ligands and inhibitors were probed by intrinsic tryptophan fluorescence. In the presence of sodium, sugars increase intrinsic fluorescence (maximum 17%) in a saturable manner in the following order alpha-MDG >D-Glu approximately D-Gal >> D-Man >D-All, with no effect of L-Glu. Apparent affinities ranging from 0.65 to 10.4 mM were observed. In addition, D-Glu increased the accessibility of the Trps to hydrophilic collisional quenchers. On the contrary, the transport inhibitor phlorizin decreased Trps fluorescence in a sodium-dependent manner by 50% with a red shift of 4-6 nm and decreased quencher accessibility, these effects were saturable with a high affinity of 5 microM. Furthermore, the positioning of the tryptophans in the reconstituted transporter was investigated. hSGLT1 Trps fluorescence was reduced by N-bromosuccinimide treatment maximally 25% in membranes and 65% in solution. The fluorescence was also significantly but differently quenched by the lipid-soluble spin labeled probes 5-Doxyl-phosphatidylcholine (40%) and 12-Doxyl-phosphatidylcholine (26%). Depth-calculation using the parallax method suggested a location of Trps at an average depth of 10 angstrom from the center of the bilayer. These studies demonstrate the existence of different conformational states of the membrane-embedded transporter in its glucose-free form, as sodium-glucose-carrier complex and as sodium-phlorizin-carrier complex. They further indicate that most of the Trp residues in hSGLT1 are located in hydrophobic regions of the protein or in contact with the lipid bilayer of the membrane. There, they are located close to the membrane-water interface contributing to the vectorial nature of the transporter.
Kumar
Azad
A
Max Planck Institute of Molecular Physiology, Otto-Hahn-Str 11, Dortmund, 44227, Germany.
Tyagi
Navneet K
NK
Kinne
Rolf K H
RK
D003497:Cyclic N-Oxides / Q000737:chemistry; D005453:Fluorescence; D006801:Humans; D008024:Ligands; D008081:Liposomes / Q000737:chemistry; D008566:Membranes / Q000737:chemistry; D010695:Phlorhizin / Q000494:pharmacology; D010743:Phospholipids / Q000737:chemistry; D011487:Protein Conformation; D051269:Sodium-Glucose Transporter 1 / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D013113:Spin Labels; D014364:Tryptophan / Q000032:analysis*
C042802:12-doxylstearoyl-3-phosphatidylcholine; C042801:5-doxylpalmitoyl-3-phosphatidylcholine; D003497:Cyclic N-Oxides; D008024:Ligands; D008081:Liposomes; D010743:Phospholipids; C495674:SLC5A1 protein, human; D051269:Sodium-Glucose Transporter 1; D013113:Spin Labels; D014364:Tryptophan; D010695:Phlorhizin